World's Best Scientists 2026 revealed!
Thira Sirisanthana

Thira Sirisanthana

D-Index & Metrics

Microbiology

D-Index
42
Citations
7985
World Ranking
5335
National Ranking
21

Thira Sirisanthana publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Thira Sirisanthana sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 136 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Thira Sirisanthana D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Thira Sirisanthana sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 42 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Thira Sirisanthana is affiliated with Chiang Mai University in Thailand and has contributed to the field of medicine with a focus on HIV-related health complications, cardiovascular risks, and infectious diseases. Their research spans various subfields including epidemiology, emergency medicine, surgery, endocrinology, diabetes and metabolism, and infectious diseases.

Their recent research contributions include studies published in the Journal of Antimicrobial Chemotherapy, with two notable papers:

  • "Drug-drug interaction between itraconazole capsule and efavirenz in adults with HIV for talaromycosis treatment," published in 2020.
  • "Changes in atherosclerotic cardiovascular disease risk over time among people living with HIV," published in 2024.

These works address antifungal resistance and susceptibility, fungal infections, and the implications of lipoproteins on cardiovascular health among people living with HIV, reflecting an interdisciplinary approach melding infectious disease treatment with metabolic and cardiovascular considerations.

Frequent collaborators in their research include:

  • Romanee Chaiwarith
  • Sanjay Pujari
  • Weisi Chen
  • Kathy Petoumenos
  • Agus Somia

The majority of Thira Sirisanthana's publications have appeared in the Journal of Antimicrobial Chemotherapy, indicating a focused engagement with antimicrobial therapy and related clinical studies.

Main fields and subfields engaged by Sirisanthana include:

  • Medicine
  • Epidemiology
  • Emergency Medicine
  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Infectious Diseases

Key topics of investigation are:

  • HIV-related health complications and treatments
  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Fungal Infections and Studies
  • Antifungal resistance and susceptibility
  • Pneumocystis jirovecii pneumonia detection and treatment

Best Publications

  • Disseminated Penicillium marneffei infection in southeast Asia

    K Supparatpinyo;C Khamwan;V Baosoung;T Sirisanthana

  • Penicillium marneffei Infection and Recent Advances in the Epidemiology and Molecular Biology Aspects

    Nongnuch Vanittanakom;Chester R. Cooper;Matthew C. Fisher;Thira Sirisanthana

  • Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America

    Benjamin H. Chi;Constantin T. Yiannoutsos;Andrew O. Westfall;Andrew O. Westfall;Jamie E. Newman

  • Amphotericin B and Itraconazole for Treatment of Disseminated Penicillium marneffei Infection in Human Immunodeficiency Virus-Infected Patients

    Thira Sirisanthana;Khuanchai Supparatpinyo;Joseph Perriens;Kenrad E. Nelson

  • Penicillium marneffei Infection in Patients Infected with Human Immunodeficiency Virus

    Khuanchai Supparatpinyo;Siri Chiewchanvit;Siri Chiewchanvit;Panit Hirunsri;Panit Hirunsri;Chantana Uthammachai;Chantana Uthammachai

  • A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus

    Khuanchai Supparatpinyo;Joseph Perriens;Kenrad E. Nelson;Thira Sirisanthana

  • Clinical Presentation and Risk Behaviors of Patients with Acquired Immunodeficiency Syndrome in Thailand, 1994–1998: Regional Variation and Temporal Trends

    Suwat Chariyalertsak;Thira Sirisanthana;Orapan Saengwonloey;Kenrad E. Nelson

  • Efficacy of Highly Active Antiretroviral Therapy in HIV-Infected Children Participating in Thailand's National Access to Antiretroviral Program

    Thanyawee Puthanakit;Aurmporn Oberdorfer;Noppadon Akarathum;Suparat Kanjanavanit

  • Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children

    Thanyawee Puthanakit;Peninnah Oberdorfer;Noppadon Akarathum;Pornphun Wannarit

  • Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.

    Khuanchai Supparatpinyo;K. E. Nelson;W. G. Merz;B. J. Breslin

  • Disclosure of HIV/AIDS diagnosis to HIV‐infected children in Thailand

    Peninnah Oberdorfer;Thanyawee Puthanakit;Orawan Louthrenoo;Chawanun Charnsil

  • Hospitalization and Mortality among HIV-Infected Children after Receiving Highly Active Antiretroviral Therapy

    Thanyawee Puthanakit;Linda Aurpibul;Peninnah Oberdorfer;Noppadon Akarathum

  • Anthrax of the Gastrointestinal Tract

    Thira Sirisanthana;Arthur E. Brown

  • A Controlled Trial of Itraconazole as Primary Prophylaxis for Systemic Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection in Thailand

    Suwat Chariyalertsak;Khuanchai Supparatpinyo;Thira Sirisanthana;Kenrad E. Nelson

  • Case-Control Study of Risk Factors for Penicillium marneffei Infection in Human Immunodeficiency Virus-Infected Patients in Northern Thailand

    Suwat Chariyalertsak;Thira Sirisanthana;Khuanchai Supparatpinyo;Jutharat Praparattanapan

  • Epidemiologic, clinical and laboratory features of scrub typhus in thirty Thai children.

    Virat Sirisanthana;Thanyawee Puthanakit;Thira Sirisanthana

  • Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.

    Thomas B. Campbell;Laura M. Smeaton;N. Kumarasamy;Timothy Flanigan

  • Mycoses in AIDS patients

    B. Dupont;D.W. Denning;D. Marriott;A. Sugar

  • Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a clue to the reservoir?

    Suwat Chariyalertsak;Thira Sirisanthana;Khuanchai Supparatpinyo;Kenrad E. Nelson

  • Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients.

    Thira Sirisanthana;Khuanchai Supparatpinyo

  • Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei

    S. Chariyalertsak;P. Vanittanakom;K.E. Nelson;T. Sirisanthana

  • Detection of Cell Wall Mannoprotein Mp1p in Culture Supernatants of Penicillium marneffei and in Sera of Penicilliosis Patients

    Liang Cao;King-Man Chan;Daliang Chen;Nongnuch Vanittanakom

  • Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

    Linda Aurpibul;Thanyawee Puthanakit;Benjamin Lee;Ampica Mangklabruks

Frequent Co-Authors

Adeeba Kamarulzaman
Adeeba Kamarulzaman University of Malaya
Matthew Law
Matthew Law University of New South Wales
Kenrad Edwin Nelson
Kenrad Edwin Nelson Johns Hopkins University
Shinichi Oka
Shinichi Oka Kumamoto University
Jennifer F Hoy
Jennifer F Hoy Monash University
Niwat Maneekarn
Niwat Maneekarn Chiang Mai University
Teruo Kirikae
Teruo Kirikae Juntendo University
Robin Wood
Robin Wood University of Cape Town
Bertrand Dupont
Bertrand Dupont Necker-Enfants Malades Hospital
Beatriz Grinsztejn
Beatriz Grinsztejn Oswaldo Cruz Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens the door to diverse career pathways, including research, healthcare, and specialized medical fields. For those exploring further education, programs such as the easy MPH online programs provide accessible options to build on a microbiology background, especially in public health administration and epidemiology.

Career options extend beyond traditional lab roles. For instance, becoming a child life specialist salary can be rewarding for those interested in supporting children’s health and development, integrating scientific knowledge with patient care. Additionally, healthcare roles like a functional nurse practitioner combine clinical expertise with holistic approaches, which can be a valuable complement to a microbiology education.

Importantly, online degree options are increasingly inclusive. Individuals with diverse backgrounds can benefit from programs highlighted in resources such as degrees felons can get, which offer pathways to meaningful careers in science and healthcare.

Best Scientists Citing Thira Sirisanthana

Trending Scientists

Recently Published Articles